A Retrospective, Cross-sectional Hospital-based Study to Determine the Epidemiological, Clinical and Comorbidity Characteristics in Older Adults with Psoriasis
Table 4.
Systemic comorbidity profile inElderly and Ultra elderly psoriatic groups.
|
| Characteristics |
Elderly |
Ultraelderly |
|
|
|
|
|
| Freq |
% |
Freq |
% |
Grand Total |
% |
P value |
|
|
| Associated Comorbidity |
No |
56 |
39.7 |
7 |
31.8 |
63 |
38.7 |
0.24 |
|
|
| Yes |
85 |
60.3 |
15 |
68.2 |
100 |
61.3 |
|
|
|
| Arterial Hypertension(HTN) |
67 |
47.5 |
14 |
63.6 |
81 |
49.7 |
0.12 |
|
|
|
< 5 years |
13 |
19.4 |
3 |
21.4 |
16 |
19.8 |
|
|
|
| 5-10 years |
24 |
35.8 |
2 |
9.09 |
26 |
32.1 |
|
|
|
| > 10 years |
30 |
44.8 |
9 |
40.9 |
39 |
48.2 |
|
|
|
| Anti HTN Drugs |
|
|
| Calcium Channel Blockers |
52 |
77.6 |
13 |
92.9 |
65 |
80.3 |
|
|
|
| Diuretics |
9 |
13.4 |
1 |
4.6 |
10 |
12.4 |
|
|
|
| Angiotensin Converting Enzyme Inhibitors |
15 |
22.4 |
5 |
22.7 |
20 |
24.7 |
|
|
|
| Angiotensin Receptor Blockers |
39 |
58.2 |
7 |
31.8 |
46 |
56.8 |
|
|
|
| Diabetes Mellitus type II(DM) |
29 |
20.6 |
7 |
31.8 |
36 |
22.1 |
|
|
|
|
< 5 years |
6 |
20.7 |
0 |
0 |
6 |
16.7 |
|
|
|
|
5-10 years |
15 |
51.7 |
0 |
0 |
15 |
9.2 |
|
|
|
|
> 10 years |
8 |
27.6 |
7 |
31.82 |
15 |
9.2 |
|
|
|
| Hypoglycaemic Drugs |
|
|
| Metformin |
25 |
86.2 |
7 |
31.8 |
32 |
88.9 |
|
|
|
| Sulfonylureas |
21 |
72.4 |
7 |
31.8 |
28 |
77.8 |
|
|
|
| Thiozolididiones |
7 |
24.1 |
3 |
13.6 |
10 |
27.8 |
|
|
|
| Acarbose |
1 |
3.5 |
0 |
0 |
1 |
2.8 |
|
|
|
| Meglitides |
6 |
20.7 |
2 |
9.1 |
8 |
22.2 |
|
|
|
| Insulin |
1 |
3.5 |
0 |
0 |
1 |
2.8 |
|
|
|
| Dyslipidemia |
33 |
23.4 |
9 |
41 |
42 |
25.8 |
|
|
|
|
< 5 years |
5 |
15.2 |
1 |
1.1 |
6 |
14.3 |
|
|
|
|
5-10 years |
16 |
48.5 |
1 |
1.1 |
17 |
40.5 |
|
|
|
|
> 10 years |
12 |
36.4 |
7 |
77.8 |
19 |
45.2 |
|
|
|
| Ischaemic Heart Disease |
11 |
7.8 |
6 |
27.3 |
17 |
10.43 |
|
|
|
|
< 5 years |
3 |
27.3 |
3 |
50 |
6 |
35.3 |
|
|
|
|
5-10 years |
4 |
36.4 |
0 |
0 |
4 |
23.5 |
|
|
|
|
> 10 years |
4 |
36.4 |
3 |
50 |
7 |
41.2 |
|
|
|
| Metabolic syndrome |
22 |
15.6 |
7 |
31.8 |
29 |
17.8 |
|
|
|
| Hypothyroidism |
4 |
2.8 |
1 |
4.55 |
5 |
3.1 |
|
|
|
|
< 5 years |
0 |
|
0 |
0 |
0 |
0 |
|
|
|
|
5-10 years |
3 |
75 |
0 |
0 |
3 |
60 |
|
|
|
|
> 10 years |
1 |
25 |
1 |
100 |
2 |
40 |
|
|
|
| Thyroxine |
3 |
75 |
1 |
4.55 |
4 |
80 |
|
|
|
| Benign Prostatic Hyperplasia |
5 |
3.6 |
1 |
4.55 |
6 |
5.2 |
|
|
|
|
< 5 years |
2 |
40 |
1 |
100 |
3 |
50 |
|
|
|
|
5-10 years |
1 |
20 |
0 |
0 |
1 |
16.7 |
|
|
|
|
> 10 years |
2 |
40 |
0 |
0 |
2 |
33.3 |
|
|
|
| Athritis except Psoriatic arthritis |
4 |
2.8 |
0 |
0 |
4 |
2.4 |
|
|
|
|
< 5 years |
1 |
25 |
0 |
0 |
1 |
25 |
|
|
|
|
5-10 years |
1 |
25 |
0 |
0 |
1 |
25 |
|
|
|
|
> 10 years |
2 |
50 |
0 |
0 |
2 |
50 |
|
|
| Renal disease |
2 |
1.4 |
0 |
0 |
2 |
1.2 |
|
|
|
|
< 5 years |
0 |
0 |
0 |
0 |
0 |
0 |
|
|
|
|
5-10 years |
1 |
50 |
0 |
0 |
1 |
50 |
|
|
|
|
> 10 years |
1 |
50 |
0 |
0 |
1 |
50 |
|
|
|
| Others |
8 |
5.7 |
2 |
9.1 |
10 |
6.1 |
|
|
|
|
< 5 years |
3 |
37.5 |
1 |
50 |
4 |
40 |
|
|
|
|
5-10 years |
3 |
37.5 |
0 |
0 |
3 |
30 |
|
|
|
|
> 10 years |
2 |
25 |
1 |
50 |
3 |
30 |
|
|
|
|
